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Cellular/Molecular
ACR-12 Ionotropic Acetylcholine Receptor Complexes
Regulate Inhibitory Motor Neuron Activity in Caenorhabditis
elegans
Hilary A. Petrash, Alison Philbrook, Marian Haburcak, Belinda Barbagallo, andMichael M. Francis
Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Heterogeneity in the composition of neurotransmitter receptors is thought to provide functional diversity that may be important in
patterning neural activity and shaping behavior (Dani and Bertrand, 2007; Sassoe`-Pognetto, 2011). However, this idea has remained
difficult to evaluate directly because of the complexity of neuronal connectivity patterns and uncertainty about the molecular composi-
tion of specific receptor types in vivo. Here we dissect how molecular diversity across receptor types contributes to the coordinated
activity of excitatory and inhibitory motor neurons in the nematode Caenorhabditis elegans. We show that excitatory and inhibitory
motor neurons express distinct populations of ionotropic acetylcholine receptors (iAChRs) requiring the ACR-12 subunit. The activity
level of excitatory motor neurons is influenced through activation of nonsynaptic iAChRs (Jospin et al., 2009; Barbagallo et al., 2010). In
contrast, synaptic coupling of excitatory and inhibitory motor neurons is achieved through a second population of iAChRs specifically
localized at postsynaptic sites on inhibitory motor neurons. Loss of ACR-12 iAChRs from inhibitory motor neurons leads to reduced
synaptic drive, decreased inhibitory neuromuscular signaling, and variability in the sinusoidal motor pattern. Our results provide new
insights intomechanisms that establish appropriately balanced excitation and inhibition in the generation of a rhythmicmotor behavior
and reveal functionally diverse roles for iAChR-mediated signaling in this process.
Introduction
Nicotinic or ionotropic acetylcholine receptors (iAChRs) play
diverse roles in nervous systems ranging from nematodes to
mammals. A large variety of alternative iAChR subunit combina-
tions, each with distinguishing features, participate in neural cir-
cuits throughout the CNS (Dani and Bertrand, 2007). In the
mammalian brain, iAChRs are most commonly localized to syn-
aptic terminals or extrasynaptic sites in which they function to
modulate neurotransmitter release or regulate neuronal excit-
ability, although considerable functional variability exists (Mulle
et al., 1991; Grady et al., 2009; Mackey et al., 2012). Specific
neuronal iAChR subtypes are preferentially targeted by addictive
drugs, such as nicotine (Tapper et al., 2004; Fowler et al., 2011),
and iAChRs are critically involved in the process of addiction as
well as the pathophysiology of a variety of neurological disorders
(Tuesta et al., 2011). Because of the diversity of molecules in-
volved, the limited availability of pharmacological tools that tar-
get specific iAChR subtypes, and the complexity of neuronal
connectivity patterns, it remains difficult to address how partic-
ular iAChR subunit combinations contribute to the function of
specific neural circuits in the mammalian CNS.
Here we use genetic and electrophysiological approaches to
investigate how specific iAChR subtypes contribute to synaptic
function and circuit activity using an anatomically well-defined
motor circuit of the nematode Caenorhabditis elegans. In C. el-
egans, excitatory cholinergic motor neurons (ACh MNs) make
synaptic contacts onto both muscle cells and GABAMNs that, in
turn, make inhibitory synaptic contacts onto opposing muscula-
ture (see Fig. 3A) (White et al., 1986). Proper function of this
circuit produces temporally coordinated and balanced excitatory
and inhibitory signals that pattern movement. Although the an-
atomical connectivity of this circuit has been well characterized,
the signaling mechanisms that underlie coordinated MN activity
are not well understood.Many of the 29 iAChR subunits encoded
by theC. elegans genome are expressed inMNs (Cinar et al., 2005;
Fox et al., 2005; Jones et al., 2007; Rand, 2007). In particular, ACh
MNs express a class of heteromeric acetylcholine-gated ion chan-
nel complexes known as ACR-2R (Jospin et al., 2009; Barbagallo
et al., 2010). ACR-2Rs are composed of five distinct subunits
(ACR-2, ACR-3, UNC-38, UNC-63, and ACR-12), each of which
is essential for function in heterologous expression studies. Loss
of ACR-2R leads to relatively subtle changes in behavior; how-
ever, gain-of-function acr-2 mutations have profound conse-
quences, including hyperactivation and, in extreme cases, death
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of AChMNs (Jospin et al., 2009; Barbagallo et al., 2010). Loss-of-
function and cell-specific expression experiments demonstrated
that the effects of acr-2(gf) were dependent on expression of the
partnering iAChR subunit acr-12 in ACh MNs.
We show here that acr-12 is also expressed inGABAMNs, and
a distinct population of iAChRs requiring ACR-12 appears spe-
cifically localized at postsynaptic sites on GABA MN processes.
Loss of ACR-12 iAChRs from inhibitory MNs leads to reduced
synaptic drive, decreased inhibitory neuromuscular signaling,
and variability in the sinusoidal motor pattern characteristic of
nematode movement. Together, our results suggest that ACR-12
iAChRs regulate motor circuit activity by contributing to the
synaptic coupling of excitatory and inhibitory MNs.
Materials andMethods
C. elegans strains. C. elegans strains were grown under standard laboratory
conditions at 22°C. All strains are derivatives of the N2 Bristol strain (wild
type). Transgenic strains were obtained by microinjection to achieve germ-
line transformation. Multiple independent extragenic lines were obtained
for each transgenic strain, anddatapresentedare fromasingle representative
transgenic line unless noted otherwise. In all cases, lin-15(n765ts) mu-
tants were injected with the lin-15 rescuing plasmid (pL15Ek; 30 ng/l)
and one or more of the following plasmids: pPRB5 [Punc-47::mCherry],
pPRB6 [Pacr-2::mCherry], pPRB47 [Pacr-2::mCherry-RAB-3], pPRB53
[ACR-12–GFPICL], pPRB77 [Pacr-2::ACR-12–GFPICL], pHP7 [Punc-47::
ACR-12–GFPICL], and pAG21 [ACR-12–GFPC-term]. Stably integrated lines
weregeneratedbyx-ray integrationandoutcrossedat least four times towild
type. The following strains were used in this study: IZ914: acr-12(ok367)X;
IZ853: acr-12(ok367)X;ufIs57[ACR-12–GFPICL]; IZ984: acr-12(ok367);
ufIs78[Pacr-2::ACR-12::GFPICL]; IZ556: acr-12(ok367);ufIs92[Punc-47::
ACR-12–GFPICL]; IZ941: unc-49(e382)III;acr-12(ok367)X; IZ33: unc-
29(x29);acr-16(ok789); IZ514: unc-29(x29);acr-16(ok789);acr-12(ok367);
IZ629: ufIs38[ACR-12–GFPC-term];ufIs34[Punc-47::mCherry]; IZ651: ufIs38
[ACR-12–GFPC-TERM];ufIs43[Pacr-2::mCherry]; IZ632: ufIs26[Punc-4::
mCherry];ufIs38[ACR-12–GFPC-TERM]; IZ557: ufIs63[Pacr-2::mCherry-
RAB-3];ufIs92[Punc-47::ACR-12–GFPICL]; CB382: unc-49(e382)III; IZ712:
acr-12(uf77)X; RB1559: acr-2(ok1887)X.
Molecular biology. The ACR-12–GFPICL transgene (pPRB53) was gen-
erated by cloning the green fluorescent protein (GFP) coding sequence
in-frame into the sequence of an acr-12 genomic fragment (1514 to
4799 bp relative to the translational start site) encoding the intracellu-
lar loop (ICL) between transmembrane domains TM3 andTM4.As is the
case for other iAChR subunits, incorporation of GFP at this position
yielded a functional construct (Nashmi et al., 2003; Francis et al., 2005),
as demonstrated by ACR-12–GFPICL localization in neuronal processes
and rescue of acr-12mutants. pAG21 (ACR-12–GFPC-term)was provided
by Alexander Gottschalk (Goethe University, Frankfurt, Germany) and
was used in cell identifications (see Fig. 2). ACR-12–GFPC-term fluores-
cence was primarily confined to cell bodies. Punc-47::ACR-12–GFPICL
(pHP7) and Punc-47::ACR-12–GFPICL (pPRB77) were generated by
subcloning a 4.9 kb NruI/BglI fragment containing GFP from pPRB53
into constructs encoding the acr-12 cDNA control of the appropriate
promoters (pBB25 and pHP3, respectively). Punc-47::mCherry (pPRB5)
was generated by subcloningmCherry coding sequence downstream of a
1.3 kb promoter for the unc-47 gene. Pacr-2::mCherry (pPRB6) was gen-
erated by subcloning a 3.3 kb promoter for the acr-2 gene upstreamof the
mCherry coding sequence.
Microscopy. Confocal microscopy was performed using a Carl Zeiss
Axioskop 2microscope system and LSM Pascal 5 imaging software (Carl
Zeiss). All images used staged animals 24 h after the L4 stage and were
processed using NIH ImageJ software. For all synapse quantification, a
region of the dorsal cord directly across from the vulva was imaged.
Synapses were quantified within a 50m region of interest by threshold-
ing fluorescence intensity and using the analyze particles module in NIH
ImageJ software. The percentage of overlap with presynaptic RAB-3 was
determined by quantifying the number of mCherry puncta that were
positioned either directly apposing or overlapping with ACR-12::GFP
fluorescent signal.
Behavioral assays.All behavioral analyses were performed using staged
populations of young adult animals (24 h after L4) at room temperature
(22–24°C). Strains were scored in parallel, with the researcher blinded to
genotype. For aldicarb assays, staged populations of adult animals (10)
were transferred to nematode growth medium plates containing 1 mM
aldicarb (ChemService), and movement was assessed every 15 min for
2 h. Movies and still images for behavioral analyses were obtained using
an Olympus SZ61 upright microscope equipped with a FireWire camera
(Imaging Source). For gross movement, individual worms were trans-
ferred to large unseeded plates and assayed manually. Body bend ampli-
tudes were determined using NIH ImageJ software. The distance
between the deepest point of the bend and a line tangent to the tip of the
head and the body was measured. This measurement was then normal-
ized to the length of each animal and averaged to generate a value for
average body bend amplitude.
Electrophysiology. Endogenous postsynaptic currents (PSCs) were re-
corded from body wall muscles as described previously (Francis et al.,
2005). The extracellular solution consisted of the following (in mM):150
NaCl, 5 KCl, 4 MgCl2, 1 CaCl2, 15 HEPES, and 10 glucose, pH 7.4,
osmolarity adjusted with 20 sucrose. The intracellular fluid consisted of
the following (in mM):115 K-gluconate, 25 KCl, 0.1 CaCl2, 50 HEPES, 5
Mg-ATP, 0.5 Na-GTP, 0.5 cGMP, 0.5 cAMP, and 1 BAPTA, pH 7.4,
osmolarity adjusted with 10 sucrose. For some experiments measuring
GABA-mediated currents, the intracellular solution contained 115 mM
KCl and 25mMK-gluconate, enablingmeasurement of inward inhibitory
current responses (chloride efflux). At least 60–90 s of continuous data
were used in the analysis. Data analysis was performed using Igor Pro
(Wavemetrics) and Mini Analysis (Synaptosoft) software. Statistical
comparisons were made by Student’s t test using GraphPad Prism.
Results
Loss of ACR-12 leads to heightened excitability
acr-12 encodes a 573 aa iAChR subunit with significant homol-
ogy to the ACR-8-like group of C. elegans subunits and more
distant homology to mammalian neuronal heteromeric  sub-
units such as 6 (Fig. 1) (Jones et al., 2007). To investigate the
contribution of ACR-12 receptor complexes to the excitability of
neurons in the motor circuit, we evaluated independent strains
carrying putative loss-of-function alleles of acr-12 during acute
exposure to the cholinesterase inhibitor aldicarb. Treatment ofC.
elegans with aldicarb leads to elevated levels of synaptic ACh and
causes paralysis over time attributable to prolonged muscle con-
traction (Nguyen et al., 1995). The contractile state of muscles
reflects the summed activity of excitatory ACh and inhibitory
GABA synaptic inputs; genetic mutations that alter this balance
will shift the time course over which aldicarb leads to paralysis.
For example, manipulations that reduce or eliminate inhibitory
GABA signaling cause enhanced muscle activation and more
rapid paralysis (Loria et al., 2004; Vashlishan et al., 2008). acr-
12(uf77)was isolated as a suppressor of acr-2(gf) and is amissense
mutation affecting a splice acceptor site that results in premature
termination before transmembrane domain 4 (amino acids 387)
(Barbagallo et al., 2010). acr-12(ok367) is a deletion mutation
that eliminates 1368 bp of chromosomal DNA, including se-
quence encoding transmembrane domains 1–3 (Fig. 1A,B).
Strains carrying either of these alleles were viable, and gross con-
nectivity of the nervous system was normal (data not shown),
indicating that ACR-12 is not required for normal development
of the nervous system. We found the acr-12(uf77) and acr-
12(ok367) mutations both accelerated the time course of
aldicarb-induced paralysis (Fig. 1C), suggesting that loss of
ACR-12 led to enhanced excitability. In contrast, previous work
showed that removal of ACR-2Rs slightly delayed paralysis in
response to aldicarb treatment (Jospin et al., 2009; Barbagallo et
al., 2010; Fig. 1C). The differential effects of aldicarb across acr-2
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and acr-12mutants suggested that ACR-12 has additional roles in
the nervous system independent of ACR-2. To better define po-
tential functions for ACR-12 signaling, we constructed double
mutants lacking both acr-12 and unc-49. The unc-49 gene en-
codes an essential subunit of ionotropic GABAA-like receptors at
inhibitory neuromuscular synapses, and mutations in unc-49
cause aldicarb hypersensitivity (Fig. 1C) (Bamber et al., 1999).
unc-49;acr-12 double mutants exhibited no additional hypersen-
sitivity beyond that of unc-49 single mutants, suggesting that
acr-12 and unc-49may act in the same pathway.
acr-12 is reported to have broad expression in the nervous
system (Gottschalk et al., 2005), but a precise description of the
MN classes that express acr-12 has remained unclear. To address
this issue, we generated transgenic strains expressing ACR-12
tagged with GFP at the C terminus together with various red
fluorescent reporters labeling defined classes of ventral cord (VC)
MNs and examined the cellular distribution of ACR-12–GFP.
ACR-12–GFP fluorescence was broadly visible in MN cell bodies
and overlappedwith a reporter that specifically labeled AChMNs
(Pacr-2::mCherry) (Fig. 2B). We also examined the coexpression
of ACR-12–GFP with a red fluorescent protein reporter
(Punc-4::mCherry) that labels a subset of AChMNs (A class) and
theVCneurons that are primarily involved in egg laying (Lickteig
et al., 2001; Bany et al., 2003). We observed partial overlap of
ACR-12–GFP with Punc-4::mCherry and noted that ACR-12–
GFP fluorescence was absent from VC MNs (data not shown).
Additional GFP fluorescence was clearly visible in neuronal
cell bodies along the VC that were not labeled by either
Pacr-2::mCherry or Punc-4::mCherry. The cell bodies of GABA
MNs are also located in the ventral nerve cord. To test whether
the additional neurons expressing ACR-12–GFP were GABA
MNs, we imaged animals coexpressing ACR-12–GFP with a re-
porter labeling GABAneurons (Punc-47::mCherry) and observed
overlapping fluorescent signals (Fig. 2C). Our results show that
acr-12 is expressed in themajor classes of ACh (DA, VA, DB, VB)
and GABA (DD and VD) MNs that have primary functions in
locomotory control. Because expression of some ACR-2R con-
stituents (e.g., acr-2 and acr-3) is limited to ACh MNs (Jospin et
al., 2009; Barbagallo et al., 2010), our findings strongly suggest
that ACR-12 contributes to molecularly distinct iAChR popula-
tions that are differentially expressed across ACh and GABA
MNs.
To dissect functional roles for ACR-12 across MN classes, we
specifically expressed ACR-12 in either ACh or GABA MN of
Figure 1. ACR-12 gene sequence. A, ACR-12 amino acid sequence. cys-loop (*), vicinal cysteines present in subunits (), GFP insertion site (green lettering), transmembrane domains (gray
shading), ok367 deletion (blue lettering), and site of uf77mutation (yellow shading) are indicated.B, Schematic of ACR-12 receptor subunit. Approximate locations of cys-loop (*), vicinal cysteines
(∧∧), GFP insertion site (green box), transmembrane domains (M1–M4), ok367 deletion (red shading), and uf77mutation (yellow star) are indicated. C, Time course of paralysis in the presence of
aldicarb (1mM) for wild-type (blue) (n 16), acr-12(ok367)mutants (red) (n 14), acr-12(uf77)mutants (gray) (n 8), unc-49(e382)mutants (brown) (n 11), unc-49;acr-12(ok367) double
mutants (green) (n 10), ACR-12–GFP rescue using the native promoter (purple) (n 12), and acr-2(ok1887)mutants (black) (n 4) are shown. Data represent mean SEM.
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acr-12mutants and tested the responses of these animals to aldi-
carb treatment (Fig. 2D). Specific expression of acr-12 in ACh
MNs did not alter the aldicarb hypersensitivity of acr-12 mu-
tants. In contrast, specific expression of acr-12 in GABA neu-
rons restoredwild-type sensitivity to aldicarb.Our results suggest
that ACR-12 receptor complexes regulate GABAMNactivity and
inhibitory neuromuscular signaling under conditions when ACh
levels are elevated.
iAChRs requiring ACR-12 have distinct patterns of
localization and functional roles across MN classes
We examined the subcellular distribution of ACR-12 in MNs by
expressing a rescuing ACR-12–GFP fusion protein under control
of the native promoter (Fig. 3B). ACR-12–GFP expression was
clearly visible in MN processes of both the ventral and dorsal
nerve cords of adult animals and exhibited two contrasting pat-
terns of fluorescence. In the ventral nerve cord, we observed re-
gions of punctate and diffuse localization, whereas in the dorsal
cord, we observed punctate fluorescence almost exclusively (Fig.
3B,C). In contrast, specific expression of ACR-12–GFP in ACh
MNsproduced only diffuse fluorescence in the ventral nerve cord
and no detectable fluorescent signal in the dorsal nerve cord (Fig.
3D). Axons and dendrites of ventrally directedAChMNs (ventral
A andB classes) extend through the ventral nerve cord. AChMNs
innervating dorsal musculature (dorsal A and B classes) also have
cell bodies in the ventral nerve cord but extend axons into the
dorsal nerve cord, in which they make dyadic synaptic contacts
with body wall musculature and dendrites of ventrally directed
GABA MNs (ventral D class) (White et al., 1986) (Fig. 3A). We
previously observed diffuse ACR-2–GFP fluorescence in the den-
drites of ACh MNs without obvious postsynaptic localization
(Barbagallo et al., 2010). Our current finding that ACR-12–GFP
is also diffusely localized in AChMN dendrites is consistent with
the notion that ACR-2 and ACR-12 partner together in hetero-
meric complexes in ACh MNs. Specific expression of ACR-12–
GFP in GABA MNs produced solely punctate fluorescence (Fig.
3E). Many of these ACR-12–GFP puncta were located immedi-
ately apposed to regions of AChMN axons in which the synaptic
vesicle marker mCherry–RAB-3 was concentrated (Fig. 3F)
(Mahoney et al., 2006; Klassen and Shen, 2007), suggesting clus-
tering opposite sites of neurotransmitter release. We quantified
fluorescence in a 50 m segment of the posterior dorsal nerve
cord and found that a majority (87  3%) of RAB-3 puncta
overlapped with ACR-12–GFP signal. However, ACR-12 puncta
weremore numerous thanRAB-3 (25 2/50Mand 15.9 2/50
M, respectively), and we noted a subset of ACR-12–GFP puncta
without obvious RAB-3 apposition, perhaps because the acr-2
promoter does not drive RAB-3 expression in all of the neurons that
are presynaptic to GABA MNs. Our results provide evidence that
ACR-12 complexes in GABA MNs are clustered in receptor fields
located opposite presynaptic specializations of AChMNs.
ACR-12 expression in GABAMNs is required for normal
inhibitory signaling
To directly test the requirement for ACR-12 in regulating MN
activity, we used standard electrophysiology recording tech-
niques to measure the frequency of synaptic events at the neuro-
muscular junction (NMJ) in vivo (Francis andMaricq, 2006).We
used two independent strategies to distinguish between GABA
and ACh PSCs: (1) recordings were made under ionic conditions
in which GABA- and ACh-mediated events were separable based
on the directionality of the currents (for details, seeMaterials and
Methods); and (2) we recorded from unc-29;acr-16 double mu-
tants that are devoid of functional iAChRs on body wall muscles
and lack excitatory neurotransmission at the NMJ (Francis et al.,
2005; Touroutine et al., 2005). Consistent with previous findings
for acr-2mutants (Jospin et al., 2009), deletion of acr-12 signifi-
cantly reduced the rate of endogenous EPSCs (37  14% de-
crease, p  0.01) (Fig. 4) but did not affect EPSC amplitude
Figure 2. ACR-12 iAChRs regulate GABA MN activity. A, Diagram of C. elegans showing
ventral nerve cord. Red box indicates approximate region imaged inB and C.B, Confocal image
showing coexpression of ACR-12–GFP (ufIs38) and a ACh MN-specific marker
(Pacr-2::mCherry, ufIs43) in the posterior ventral nerve cord. ForB and C, asterisks indicate
MN cell bodies coexpressing both reporters. Scale bars, 50m. C, Confocal image showing
coexpression of ACR-12–GFP (ufIs38) and a GABA neuron-specific marker
(Punc-47::mCherry, ufIs34 ) in the posterior ventral nerve cord. D, Time course of paralysis
in the presence of aldicarb (1 mM) for wild-type (blue) (n 14), acr-12(ok367) mutants
(red) (n 14), ACh-specific (Pacr-2) ACR-12–GFP rescue (purple) (n 10), and GABA-
specific (Punc-47 ) ACR-12–GFP rescue (black) (n 10).
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(wild-type, 28.7  1.3 pA; acr-12, 25.5 
1.2 pA, p 0.09). The reduction in EPSC
frequency was rescued by expression of an
ACR-12 rescuing transgene under control
of the native promoter. When recording
outward GABA-mediated IPSCs (25 mM
intracellular Cl), we also observed a sig-
nificant reduction in the rate of inhibitory
events in mutants lacking ACR-12 (73 
24% decrease, p  0.01; Fig. 5). We did
not observe a significant difference in the
amplitude of endogenous IPSCs (wild-
type, 26 1.8 pA; acr-12, 23.4 2 pA, p
0.05; Fig. 5A,B). When recording inward
GABA-mediated IPSCs from unc-29;
acr-16 double mutants (115 mM intracel-
lular Cl), we observed a lower basal rate
of IPSCs compared with wild-type animals. This may reflect the
differences in recording conditions used in each set of experi-
ments or secondary effects attributable to the absence of excit-
atory transmission at the NMJ. Deletion of acr-12 significantly
reduced the frequency of IPSCs in unc-29;acr-16 double mu-
tants (52  13% decrease, p  0.01; Fig. 5C,D). To distinguish
whether the reduction in IPSC frequency arose as a consequence
of loss of ACR-12 fromGABAMNs or arose as a result of reduced
excitation levels in presynaptic ACh MNs, we recorded from an-
imals that expressed acr-12 specifically in GABA MNs. The re-
duced IPSC rate was rescued by specific expression of acr-12 in
GABAMNs but not AChMNs, consistent with cell-autonomous
action of ACR-12 in GABA neurons in determining IPSC rate.
Finally, we recorded endogenous IPSCs from acr-2mutants and,
consistent with a previous report (Jospin et al., 2009), found no
significant reduction in IPSC rate (Fig. 5A,B). Thus, the reduc-
tion in endogenous IPSC frequency in acr-12(ok367) mutants
cannot be explained by decreased excitation of presynaptic ACh
MNs.Our results provide evidence that independent populations
of ACR-12 receptors act cell autonomously in ACh and GABA
MNs to regulate their activity.
ACR-12-mediated signaling ontoMNs regulates locomotion
To determine how ACR-12-mediated signaling onto MNs con-
tributes to normal locomotory behavior, we tracked animals dur-
Figure3. ACR-12 is differentially localized acrossMNpopulations.A, Schematic of C. elegans locomotory circuit. Red coloring indicates AChMNs (VA, VB, DA, andDB) andblue indicates GABAMNs
(DD and VD). Dark gray and light gray shading represent bodywall muscles. InA and C, black triangles and boxes represent sites of cholinergic (excitatory) and GABAergic (inhibitory) innervation of
muscles, respectively. Figuremodified fromWormAtlas (http://www.wormatlas.org/).B, Independent confocal images showingACR-12–GFP localization in ventral anddorsal nerve cords of young
adult animals as indicated (ufIs57 ). Positions of cell bodies are indicated bywhite arrowheads inB,D, and E. Scale bars, 10m. C, Diagramdepicting subcellular localization of ACR-12–GFP and the
presynaptic marker mCherry–RAB-3 in ACh and GABA MNs. Although ACh MNs form dyadic synapses onto both GABA MNs and muscles, only synaptic contacts between ACh and GABA MNs are
depicted for clarity. ACR-12–GFP fluorescence (green shading) is diffuse in the processes of ACh VA and VB MNs. In contrast, ACR-12–GFP fluorescence appears punctate (green circles) in the
processes of GABAergic VD and DDMNs and localizes oppositemCherry–RAB-3 fluorescent puncta (red circles) expressed in AChMNs.D, Confocal image of Pacr-2::ACR-12–GFP (ufIs78) localization
in AChMNs of the posterior ventral nerve cord. E, Confocal images of Punc-47::ACR-12–GFP (ufIs92) localization in GABAMNs of the posterior ventral and dorsal nerve cords as indicated. F, Confocal
image of the dorsal nerve cord showing apposition of mCherry–RAB-3 expressed in ACh MNs (Pacr-2, ufIs63) with ACR-12–GFP expressed in GABA MNs (Punc-47, ufIs92). Scale bar, 10m.
Figure4. EPSC frequency is reduced inacr-12mutants.A, Representative recordings of endogenous EPSCs recordedat60mV
for the indicated genotypes. Rescue refers to transgenic expression of ACR-12 in acr-12 mutants using the native promoter. B,
Average (mean SEM) EPSC frequency for the genotypes indicated. **p 0.01 fromwild type. Wild type, n 11; acr-12, n
13; rescue, n 6.
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ing exploratory movements on agar
plates. We found that deletion of acr-12
produced a reduction inmovement veloc-
ity (Fig. 6). This movement deficit could
be rescued completely by expression of an
ACR-12 rescuing transgene under control
of the native promoter. Additionally, spe-
cific expression of ACR-12 in ACh or
GABA MNs partially rescued the de-
creased movement, suggesting that nor-
mal levels of iAChR activity in both
neuron classes are important for estab-
lishing the velocity of movement. Consis-
tent with this idea, acr-12 mutants
displayed a more dramatic reduction in
velocity than acr-2 mutants. We also
noted that the sinusoidal locomotory
wave appearedmore erratic in acr-12mu-
tants (Fig. 7A). To examine this in more
detail, we monitored consecutive body
bends during extended periods of unin-
terrupted forward movement. Wild-type
animals displayed remarkable consistency
in their movement with only a few irregu-
larities in their sinusoidal tracks. In the
absence of ACR-12 receptors (ok367 and
uf77), the motor pattern was less stable,
showing significantly increased variability
from one body bend to the next (Fig. 7B,
p  0.01). This variability also led to a
modest reduction in the average ampli-
tude of body bends (14% for both uf77
and ok367, p 0.01; Fig. 7C). In contrast,
deletion of the acr-2 gene did not cause an
irregular waveformor a reduction in body
bend amplitude, indicating that loss of
ACR-2/ACR-12 heteromeric iAChRs from ACh MNs could not
account for the changes in waveform. Both of these phenotypes
were completely reversed by ACR-12 expression using the native
promoter or partially by specific expression of ACR-12 in GABA
MNs, implicating involvement of ACR-12 iAChRs expressed by
GABA MNs. Additionally, specific expression of acr-12 in ACh
MNs partially rescued the variable waveform but not the reduced
amplitude, suggesting that elevated acr-12 levels in AChMNs can
partially offset the behavioral effects of loss of ACR-12 iAChRs
from inhibitory MNs. Together, our results suggest that two
classes of iAChRs containing the ACR-12 subunit act in a distrib-
uted manner to coordinate MN activity during movement, lead-
ing to consistent locomotory output.
Discussion
Although the anatomical connectivity of the C. elegans nervous
system was described almost 30 years ago, we have only recently
been able to reconcile this static picture of nervous systemwiring
with measures of functional connectivity. One of the barriers to
progress in understanding the neural circuitmechanisms respon-
sible for the generation of movement has been an inability to
independently manipulate ACh and GABA MNs. For example,
mutations that alter the activity of ACh MNs also impact synap-
tically coupled GABA MNs. To investigate the mechanisms
by which functional connectivity among MN classes may be
achieved, we analyzed the contribution of iAChRs to motor cir-
cuit activity. Our results show that at least two classes of iAChRs
Figure 6. ACR-12 iAChRs regulate the velocity of movement. Average (mean SEM) num-
ber of body bends per minute for the genotypes indicated. Wild type, n 36; acr-12(ok367),
n 29; ACR-12–GFP rescue (native promoter), n 10; GABA-specific (Punc-47 ) ACR-12–GFP
rescue,n 10; ACh-specific (Pacr-2) ACR-12–GFP rescue,n 10; and acr-2(ok1887 ),n 17.
*p 0.05 fromwild type; **p 0.01 fromwild type.
Figure 5. Loss of ACR-12 receptors from GABA MNs reduces inhibitory signaling. A, Representative recordings of endog-
enous IPSCs recorded at 0 mV for the indicated genotypes. Rescue refers to transgenic expression of ACR-12 in acr-12
mutants under control of either the native, unc-47 (GABA) or acr-2 (ACh) promoters. B, Average (mean SEM) endoge-
nous IPSC frequency for the genotypes indicated. Wild type, n 7; acr-12, n 9; acr-12 rescue (native), n 4; acr-12
rescue (GABA), n 5, acr-12 rescue (ACh), n 4; acr-2, n 4. **p 0.01 from wild type. C, Representative recordings
of endogenous IPSCs recorded at60 mV for the indicated genotypes. Recordings were made using 115 mM KCl in the
pipette. D, Average (mean  SEM) endogenous IPSC frequency for the genotypes indicated. unc-29;acr-16, n  12;
unc-29;acr-16;acr-12, n 11. **p 0.01 from unc-29;acr-16.
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requiring ACR-12 participate in shaping motor output. Using
genetic, behavioral, and electrophysiological analysis of acr-12
mutants, we have been able to investigate the contribution of
each receptor class to motor circuit activity and behavior. Our
data suggest that synaptic coupling of ACh and GABA MNs is
achieved, at least in part, through ACR-12 iAChRs located on
GABA MNs. Mutations in acr-12 caused increased sensitivity to
drugs that enhance cholinergic activity, reduced inhibitory MN
activity, and altered the locomotory pattern during movement.
The behavioral requirement for ACR-12 iAChRs on GABAMNs
was most apparent when levels of ACh MN activity were high,
suggesting that a primary function of these receptors may be to
limit hyperactive motor output.
ACR-12 functions at synapses on GABA MNs
To address how specific iAChR classes contribute to motor cir-
cuit activity, we analyzed the expression, subcellular localization,
and loss-of-function phenotype of acr-12mutants. ACR-12::GFP
fluorescence was diffusely distributed in ACh MNs, consistent
with previous reports suggesting that heteromeric ACR-2Rs con-
taining ACR-12 may act to maintain appropriate levels of activa-
tion through an extrasynaptic mechanism (Jospin et al., 2009;
Barbagallo et al., 2010). In contrast, ACR-12::GFP fluorescence
was punctate in GABAMNs and localized opposite putative syn-
aptic release sites in ACh MNs, suggesting that ACR-12 iAChRs
located onGABAneurons are localized to synapses. Interestingly,
iAChRs play similarly diverse roles in the mammalian nervous
system in which they are primarily postsynaptic at autonomic
synapses and primarily presynaptic or extrasynaptic in the brain
(Dani and Bertrand, 2007). The two localization patterns we ob-
served might result from differences in subunit composition of
the receptor or differential expression of localization factors
unique to each MN subtype. Additional characterization of the
receptor constituents inGABAMNswill be key to addressing this
important question, as well as understanding potential effects of
differing biophysical properties across receptor types. At least two
subunits of iAChRs present on ACh MNs (ACR-2R) are not ex-
pressed inGABAMNs (Jospin et al., 2009), implying that distinct
receptor subunit combinations are expressed by each MN class.
However, a complete description of ACR-12 partners in GABA
MNs is complicated by the fact that most iAChR subunits char-
acterized to date have broad expression patterns in the nervous
system, and many are also expressed in muscle.
Our analysis provided strong evidence ACR-12 receptors reg-
ulate GABA MN activity; however, several observations indicate
that a residual level of GABA MN signaling persists in acr-12
mutants. First, acr-12 mutants exhibited variability in the loco-
motorywave and slowed grossmovement but did not phenocopy
mutants in which GABA signaling is absent. For example, acr-12
mutants did not display bilateralmuscle contractions in response
to tactile stimulation (shrinking) that are characteristic of GABA-
deficient mutants (McIntire et al., 1993; Schuske et al., 2004).
Second, acr-12 mutants carrying an additional mutation that
eliminated neuromuscular GABA signaling (unc-49;acr-12 dou-
ble mutants) showed enhanced sensitivity to aldicarb treatment
compared with acr-12 single mutants. Finally, electrophysiolog-
Figure 7. ACR-12 iAChRs are required for consistent motor pattern. A, Still images of loco-
motory paths for wild-type and acr-12(ok367) mutants as indicated. Tracks are indicated by
white dashed lines. The image shows amore severe example of the variable waveform pheno-
type in acr-12 mutants. Scale bar, 2 mm. B, Coefficient of variance for body bend amplitude
averaged over 10 consecutive body bends for genotypes indicated. Wild type, n 23; acr-
12(uf77), n 11; acr-12(ok367), n 52; rescue (native promoter), n 11; rescue (GABA-
specific), n 34; rescue (ACh-specific), n 14; acr-2(ok1887), n 13. *p 0.05 from
wild type; **p 0.01 fromwild type. C, Scatter plot of body bend amplitudes for genotypes
4
indicated. Wild type, n 45; acr-12(uf77), n 31; acr-12(ok367), n 52; rescue (native),
n 20; rescue (GABA-specific), n 20; rescue (ACh-specific), n 20; acr-2(ok1887), n 24.
Each point represents an average of three consecutive body bends for an individual animal.
Mean SEM is indicated by horizontal lines. *p 0.05 fromWT; **p 0.01 fromwild type.
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ical recordings from body wall muscles showed that GABA IPSCs
continued at a reduced rate in acr-12mutants but were not elim-
inated. These findings suggest the presence of additional mecha-
nisms for regulating inhibitory activity, either intrinsic to GABA
MNs or mediated through signaling pathways onto GABA MNs
that function independently of ACR-12. Alternatively, it is possi-
ble that there is no absolute requirement for ACR-12 in the for-
mation of functional heteromeric iAChR complexes on GABA
neurons. However, because acr-12 encodes an  subunit and
there is typically a stringent requirement for subunits in iAChR
function, this latter possibility appears less likely. Two non-
identical  subunits (UNC-38 and UNC-63) are required for
functional reconstitution of the levamisole-sensitive iAChR from
C. elegans body wall muscles (Boulin et al., 2008), and three non-
identical  subunits, including ACR-12, are each required for
functional reconstitution of the ACR-2R from C. elegans ACh
MNs (Jospin et al., 2009).
ACR-12 iAChRs in motor control
During nematode locomotion,waves ofMNactivity drivemuscle
contractions along the length of the body and propagate move-
ment (Pierce-Shimomura et al., 2008; Kawano et al., 2011; Leifer
et al., 2011).We found thatmutations in acr-12 caused significant
phenotypic changes during normal, exploratory movements.
However, the most dramatic effects of ACR-12 loss occurred
under conditions in which levels of cholinergic activity were ele-
vated by pharmacological treatment (aldicarb). In many organ-
isms, specific MN pools are recruited depending on the
behavioral output (Goulding, 2009). The effects of the acr-12
mutation observed in our experimentsmay suggest a similar pro-
cess occurs in C. elegans. Thus, under normal conditions, ACR-
12-mediated synaptic activation of GABA MNs may be less
stringently required, accounting for the relatively modest effects
of acr-12mutations during exploratory movements. In contrast,
with high levels of AChMNactivity, an increased requirement for
inhibitory signaling may be achieved through ACR-12 iAChR-
mediated recruitment of GABA MNs. In this case, synaptic acti-
vation of GABAMNsmay reinforce the sinusoidalmotor pattern
and prevent impairedmovement attributable to hyperactivemo-
tor states. Therefore, a primary role for ACR-12-mediated signal-
ing in themotor circuitmay be to limit hyperactivemotor output
through activation of GABA MNs.
In summary, we have used genetic techniques and electro-
physiology to provide a detailed analysis of neuron and circuit
function in C. elegans. We have shown that ACR-12 contributes
to at least two distinct receptor populations expressed by excit-
atory and inhibitory MNs. We propose that iAChRs requiring
ACR-12 are located at synapses onto GABA MNs, and, through
activation of these iAChRs, inhibitory MNs are recruited to pat-
tern undulatory movements.
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